Skip to main content

Advertisement

SpringerLink
Log in

Determinants of autonomic dysfunction in idiopathic Parkinson’s disease

  • ORIGINAL COMMUNICATION
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objectives

To determine demographic or disease-related factors that may influence the severity of autonomic dysfunction in idiopathic Parkinson’s disease (IPD).

Methods

532 patients with IPD aged between 55 and 75 years were included. Severity of autonomic dysfunction was assessed using a 9-item autonomic dysfunction score (ADS). In addition, several demographic factors (e. g. age, gender, comorbidities) and disease- related (e. g. motor stage, disease duration, antiparkinsonian therapy) factors were recorded. A group of 67 age-matched healthy volunteers served as a control group. Demographic and clinical data of this cross-sectional survey were analyzed by a logistic stepwise regression model to determine independent predictors of autonomic dysfunction.

Results

IPD patients showed significantly higher ADS values than controls, even in the youngest age groups and in mild disease stages. Hoehn&Yahr (H&Y) stage, disease duration, age at onset and various therapy combinations all showed significant correlations with ADS. However, stepwise logistic regression revealed that age (OR 10.71; CI 7.17–16.0) and arterial hypertension (OR 3.05; CI 1.66–5.58) were the only independent risk factors associated with autonomic dysfunction. Linear regression indicated that ADS increases with age in controls as well as in patients, but with a significantly steeper slope in the latter.

Conclusions

Autonomic dysfunction as an inherent feature of IPD is present already in early disease stages. According to a logistic regression model, the severity of autonomic dysfunction in IPD is primarily related to demographic but not to disease-related factors. This and the differences in predictors for motor versus autonomic decline may indicate at least partly independent neurodegenerative processes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Appenzeller O, Goss JE (1971) Autonomic deficits in Parkinson’s syndrome. Arch Neurol 24:50–57

    PubMed  CAS  Google Scholar 

  2. Awerbuch GI, Sandyk R (1994) Autonomic functions in early stages of Parkinson’s disease. Int J Neurosci 74:9–16

    Article  PubMed  CAS  Google Scholar 

  3. Barbeau A (1984) Etiology of Parkinson’s disease: A research strategy. Can J Neurol Sci 11:24–28

    PubMed  CAS  Google Scholar 

  4. Benarroch EE, Schmeichel AS, Parisi JE (2000) Involvement of the ventrolateral medulla in parkinsonism with autonomic failure. Neurology 54:963–968

    PubMed  CAS  Google Scholar 

  5. Braak H, Braak E (2000) Pathoanatomy of Parkinson’s disease. J Neurol 247 (Suppl 2):3–10

    Google Scholar 

  6. Braak H, Del Tredici K, Rüb U, et al. (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neuropathol Aging 24:197–211

    Google Scholar 

  7. Bradley JG, Davis KA (2003) Orthostatic hypotension. Am Fam Physician 68:2393–2398

    PubMed  Google Scholar 

  8. Camerlingo M, Aillon C, Bottacchi E, et al. (1986) Parasympathetic assessment in Parkinson’s disease. Adv Neurol 45:267–269

    Google Scholar 

  9. Daniel SE, Lees AJ (1993) Parkinson’s Disease Society Brain Bank, London: Overview and Research. J Neural Transm 39(Suppl):165–172

    CAS  Google Scholar 

  10. Del Tredici K, Rüb U, DeVos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413–426

    PubMed  Google Scholar 

  11. Edwards L, Pfeiffer RF, Quigley EM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156

    Article  PubMed  CAS  Google Scholar 

  12. Fahn S, Elton RL, and members of the UPDRS development committee (1987) Unified Parkinson’s Disease rating scale. In: Fahn S, Marsden CD, Goldstein M (eds) Recent development in Parkinson’s disease II. McMillan, New York, pp 153–163

  13. Gerritsen J, Dekker JM, TenVoorde BJ, et al. (2001) Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care 24:1793–1798

    PubMed  CAS  Google Scholar 

  14. Gilman S, Low PA,Quinn N, et al. (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98

    Article  PubMed  CAS  Google Scholar 

  15. Goetz CG, Lutge W, Tanner CM (1986) Autonomic dysfunction in Parkinson’s disease. Neurology 36:73–75

    PubMed  CAS  Google Scholar 

  16. Haapaniemi TH, Kallio MA, Korpelainen JT, et al. (2000) Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson’s disease. J Neurol 247:868–874

    PubMed  CAS  Google Scholar 

  17. Jankovic J, Kapadia AS (2001) Functional decline in Parkinson’s disease. Arch Neurol 58:1611–1615

    PubMed  CAS  Google Scholar 

  18. Johannes CB, Araujo AB, Feldman HA, et al. (2000) Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol 163:460–463

    PubMed  CAS  Google Scholar 

  19. Jost WH (1995) Disorders of autonomic regulation in Parkinson’s syndrome. Fortschr Neurol Psychiatr 63:194–205

    PubMed  CAS  Google Scholar 

  20. Jost WH (1997) Gastrointestinal motility problems in patients with Parkinson’s disease. Effects of antiparkinsonian treatment and guideline for management. Drugs Aging 10:249–258

    Article  PubMed  CAS  Google Scholar 

  21. Jost WH (2003) Autonomic dysfunction in idiopathic Parkinson’s disease. J Neurol 250(Suppl 1):28–30

    Article  Google Scholar 

  22. Korchounov A, Kessler KR, Schipper HI (2004) Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson’s disease. Acta Neurol Scand 109:45–51

    Article  PubMed  CAS  Google Scholar 

  23. Korczyn AD (1989) Autonomic nervous system screening in patients with early Parkinson’s disease. In: Przuntek H, Riederer P (eds) Early diagnosis and preventive therapy in Parkinson’s disease. Springer, Wien, pp 41–48

  24. Kupsky WJ, Grimes MM, Sweeting J, Bertsch R, Cote LJ (1987) Parkinson’s disease and megacolon: concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37:1253–1255

    PubMed  CAS  Google Scholar 

  25. Kubis N, Faucheux BA, Ransmayr G, et al. (2000) Preservation of midbrain catecholaminergic neurons in very old human subjects. Brain 123:366–373

    Article  PubMed  Google Scholar 

  26. Langston JW, Forno LS (1978) The hypothalamus in Parkinson’s disease. Ann Neurol 3:129–133

    Article  PubMed  CAS  Google Scholar 

  27. Lin HH, Torng PL, Sheu BC, Shau WY, Huang SC (2003) Urodynamically age-specific prevalence of urinary incontinence in women with urinary symptoms. Neurourol Urodyn 22:29–32

    Article  PubMed  Google Scholar 

  28. Mann DM, Yates PO (1983) Possible role of neuromelanin in the pathogenesis of Parkinson’s disease. Mech Ageing Dev 21:193–203

    Article  PubMed  CAS  Google Scholar 

  29. Martignoni E, Micieli G, Cavallini A, et al. (1986) Autonomic disorders in idiopathic Parkinsonism. J Neural Transm 22(Suppl):149–161

    CAS  Google Scholar 

  30. Martignoni E, Pacchetti C, Godi L, Micieli G, Nappi G (1995) Autonomic disorders in Parkinson’s disease. J Neural Transm 45(Suppl):11–19

    CAS  Google Scholar 

  31. Mathias CJ (2002) Neurodegeneration, parkinsonian syndromes and autonomic failure. Auton Neurosci 96:50–58

    PubMed  CAS  Google Scholar 

  32. Muthane U, Yasha TC, Shankar SK (1998) Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 43:283–287

    Article  PubMed  CAS  Google Scholar 

  33. Olanow CW, Watts RL, Koller WC (2001) An algorithm (decision tree) for the management of Parkinson’s disease (2001): treatment guidelines. Neurology 56(Suppl 5):1–88

    Google Scholar 

  34. Orskov L, Jacobsen J, Dupont E, de Fine Olivarius B, Christensen NJ (1987) Autonomic function in parkinsonian patients related to duration of disease. Neurology 37:1173–1178

    PubMed  CAS  Google Scholar 

  35. Pacchetti C, Sibilla L, Bruggi P, et al. (1990) Autonomic disturbances in Parkinson’s disease and Multisystem Atrophy: Clinical aspects. Funct Neurol 5(Suppl 4):49–56

    Google Scholar 

  36. Perkiomaki JS, Ikaheimo MJ, Pikkujamsa SM, et al. (1996) Dispersion of QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy. Hypertension 28:16–21

    PubMed  CAS  Google Scholar 

  37. Quigley EM (1996) Gastrointestinal dysfunction in Parkinson’s disease. Semin Neurol 16:245–250

    PubMed  CAS  Google Scholar 

  38. Sandyk R, Awerbuch GI (1992) Dysautonomia in Parkinson’s disease: relationship to motor disability. Int J Neurosci 64:23–33

    PubMed  CAS  Google Scholar 

  39. Sandyk R (1997) The accelerated aging hypothesis of Parkinson’s disease is not supported by the pattern of circadian melatonin secretion. Int J Neurosci 90:271–275

    PubMed  CAS  Google Scholar 

  40. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF (2002) Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey. Parkinsonism Relat Disord 8:277–284

    Article  PubMed  CAS  Google Scholar 

  41. Singer C, Weiner WJ, Sanchez-Ramos JR (1992) Autonomic dysfunction in men with Parkinson’s disease. Eur Neurol 32:134–140

    PubMed  CAS  Google Scholar 

  42. Thulesius O (1976) Pathophysiological classification and diagnosis of orthostatic hypotension. Cardiology 61 (Suppl 1):180–196

    PubMed  Google Scholar 

  43. Tilvis RS, Hakala SM, Valvanne J, Erkinjuntti T (1996) Postural hypotension and dizziness in a general aged population: a four-year follow-up of the Helsinki Aging Study. J Am Geriatr Soc 44:809–814

    PubMed  CAS  Google Scholar 

  44. Turkka JT (1987) Correlation of the severity of autonomic dysfunction to cardiovascular reflexes and to plasma noradrenaline levels in Parkinson’s disease. Eur Neurol 26:203–210

    PubMed  CAS  Google Scholar 

  45. van Dijk JG, Haan J, Zwinderman K, et al. (1993) Autonomic nervous system dysfunction in Parkinson’s disease: relationships with age, medication, duration, and severity. J Neurol Neurosurg Psychiatry 56:1090–1095

    Article  PubMed  CAS  Google Scholar 

  46. Wakabayashi W, Takahashi H(1997) Neuropathology of autonomic nervous system in Parkinson’s disease. Eur Neurol 38(Suppl 2):2–7

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Parkinson Clinic Bad Nauheim, Franz-Groedel-Str. 6, 61231, Bad Nauheim, Germany

    Alexei Korchounov MD

  2. Department of Neurology, J. W. Goethe University, Frankfurt/Main, Germany

    Kirn R. Kessler MD

  3. Clinic of Nervous Diseases, Sechenov Medical Academy, Moscow, Russia

    Nikolay N. Yakhno MD & Igor V. Damulin MD

  4. Schlossberg Clinic for Parkinson’s Disease and Multiple Sclerosis, Bad Laasphe, Germany

    Hayo I. Schipper MD

Authors
  1. Alexei Korchounov MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kirn R. Kessler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nikolay N. Yakhno MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Igor V. Damulin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hayo I. Schipper MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexei Korchounov MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korchounov, A., Kessler, K.R., Yakhno, N.N. et al. Determinants of autonomic dysfunction in idiopathic Parkinson’s disease. J Neurol 252, 1530–1536 (2005). https://doi.org/10.1007/s00415-005-0909-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-005-0909-6

Key words

Search

Navigation